Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Zenith Drugs Ltd

NSE: ZENITHDRUG · Pharmaceuticals & Biotechnology · 3 announcements

Share price: ₹42.80
Market cap: ₹73.40 Cr
Revenue (annual): ₹171.2 Cr
Net profit (annual): ₹3.94 Cr
P/E (TTM): 18.6×Sector 50.4×
Promoter holding: 69.98%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 May 2026 18:39 IST NSE

Financial Results

Zenith Drugs H2 FY26 Results: Net Profit ₹1.6 Cr, Up 14.3% YoY

Zenith Drugs Ltd reported revenue from operations of ₹93 Cr (+41.8% YoY) and net profit of ₹1.6 Cr (+14.3% YoY) for H2 FY26.

Key figure: Net profit ₹1.6 Cr · +14.3% YoY

Open full results → Read the filing ↗